Zobrazit v EDS

Cannabis.

Uloženo v:
Podrobná bibliografie
Název: Cannabis.
Autoři: Feinberg, Steven D., Aronoff, Gerald M., Ausfahl, James, Bruns, Daniel, Darnall, Beth D., Goldberg, Robert L., Haldeman, Scott, Lessenger, James E., Mandel, Steven, Mayer, Tom G., Navani, Annu H., Osbahr III, Albert J., Warren, Pamela A., Winters, Thomas H., Harris, Jeffrey S., Hegmann, Kurt T.
Zdroj: Journal of Occupational & Environmental Medicine; Dec2025, Vol. 67 Issue 12, pe860-e871, 12p
Témata: MEDICAL protocols, NEURALGIA, CANNABIDIOL, DRUG administration routes, CHRONIC pain, TRAFFIC accidents, UNIVERSITIES & colleges, HYDROCARBONS, WORK-related injuries, PAIN management, OSTEOARTHRITIS, OCCUPATIONAL medicine, CANNABIS (Genus), ENVIRONMENTAL medicine, BACKACHE, CANNABINOIDS, INDUSTRIAL safety, INDUSTRIAL hygiene
Geografický termín: UNITED States
Abstrakt: Objective: Cannabis use is expanding rapidly, and a guideline is needed to address workplace issues. Methods: The ACOEM Guidelines methodology was used to develop an evidence-based guideline. Results: There is some evidence suggesting potential efficacy of cannabis for treatment of spasticity associated with multiple sclerosis. There is no quality evidence of efficacy for treatment of common and typical work-related disorders such as back pain, chronic radiculopathy, neuropathic pain, and other acute or chronic pain disorders. Quality evidence supports lack of efficacy for postoperative pain. There are many adverse effects, including cancers, cardiovascular diseases, psychotic disorders, and safety risks. There is a rising concern that cannabis may cause schizophrenia. Conclusions: Cannabis is not recommended for treatment of typical potentially work-related conditions. Cannabis use for any purpose is not recommended for those in safety-sensitive positions. [ABSTRACT FROM AUTHOR]
Copyright of Journal of Occupational & Environmental Medicine is the property of Lippincott Williams & Wilkins and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
Databáze: Complementary Index
Popis
Abstrakt:Objective: Cannabis use is expanding rapidly, and a guideline is needed to address workplace issues. Methods: The ACOEM Guidelines methodology was used to develop an evidence-based guideline. Results: There is some evidence suggesting potential efficacy of cannabis for treatment of spasticity associated with multiple sclerosis. There is no quality evidence of efficacy for treatment of common and typical work-related disorders such as back pain, chronic radiculopathy, neuropathic pain, and other acute or chronic pain disorders. Quality evidence supports lack of efficacy for postoperative pain. There are many adverse effects, including cancers, cardiovascular diseases, psychotic disorders, and safety risks. There is a rising concern that cannabis may cause schizophrenia. Conclusions: Cannabis is not recommended for treatment of typical potentially work-related conditions. Cannabis use for any purpose is not recommended for those in safety-sensitive positions. [ABSTRACT FROM AUTHOR]
ISSN:10762752
DOI:10.1097/JOM.0000000000003548